• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchIXICO
    Picture of IXICO logo

    IXI — IXICO Share News

    7.75p0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      £16.97m
    • Enterprise Value
      £15.85m
    • Revenue
      £6.53m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • IXI Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    IXI Dividends
    • Holding(s) in Company

      28/04/2026 10:49
    • Holding(s) in Company

      27/04/2026 16:02
    • Holding(s) in Company

      27/04/2026 15:57
    • Ixico Plc Canaccord Genuitygrp: Holding(s) in Company

      27/04/2026 15:55
    • Holding(s) in Company

      27/04/2026 13:51
    • Holding(s) in Company

      27/04/2026 11:13
    • Holding(s) in Company

      24/04/2026 15:30
    • Issue of Equity

      22/04/2026 12:40
    • UK's IXICO half-year revenue rises 23% on new contracts, margins rise

      21/04/2026 07:10
    • Trading Update

      21/04/2026 07:00
    • Result of Retail Offer

      07/04/2026 13:14
    • Retail Offer

      31/03/2026 07:01
    • Placings and Subscription

      31/03/2026 07:00
    • Brief: IXICO Announces About 1.5 Mln Stg Contract Extension

      12/02/2026 07:19
    • Brief: IXICO FY Gross Margin 49%

      09/12/2025 07:00
    • Financial Results for year ended 30 September 2025

      09/12/2025 07:00
    • Operational Update

      01/12/2025 07:00
    • Notice of 2025 Full Year Results and IMC

      27/11/2025 07:00
    • Brief: IXICO Announces Phase 3 Clinical Trial Contract Win Worth Over 3.5 Mln Stg Over Four Years

      17/11/2025 07:19
    • Clinical Trial Contract Win

      17/11/2025 07:00
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.